Cancer News and Research

Latest Cancer News and Research

AACR recognizes scientists whose contributions to cancer field have extraordinary impact

Five University of California, San Diego scientists and professors are among the first class of the Fellows of the American Association for Cancer Research Academy, created to recognize researchers whose scientific contributions have propelled significant innovation and progress against cancer.

29 Mar 2013

Porter Adventist Hospital to discuss TIA and their connection to future stroke risk

On Tuesday, April 9, Porter Adventist Hospital will be hosting an important community class discussing ministrokes, or transient ischemic attacks (TIA), and their connection to future stroke risk.

29 Mar 2013

Study finds HPV improves survival in African Americans with oropharyngeal cancer

Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, according to a newly published study from Henry Ford Hospital in Detroit.

29 Mar 2013

Viewpoints: Budget woes leave Democrats with painful choices; David Kessler on health hazards of antibiotics in meat; the pros and cons of not hiring smokers

USA Today: Entitlements Or Investment? Democrats Must Pick Democrats therefore face a fundamental and inescapable choice: they can support funding current consumption, especially by older Americans who are not working, or future investment, particularly in scientific research and innovation.

29 Mar 2013

Study: Diabetes drug slows down ageing process by mimicking the effects of dieting

A widely prescribed type 2 diabetes drug slows down the ageing process by mimicking the effects of dieting, according to a study published today using worms to investigate how the drug works.

29 Mar 2013

MD Anderson researchers named Fellows to new AACR academy

Five researchers and leaders from The University of Texas MD Anderson Cancer Center have been named Fellows to a new academy launched by the world's oldest and largest organization dedicated to cancer research, the American Association for Cancer Research.

29 Mar 2013

Drug costs and pricing issues touch hospitals, independent pharmacies

NPR reports on how one hospital made what is termed an "unusual decision" -- it chose to not stock a new drug because it was very costly.

29 Mar 2013

Research shows certain cells take on new identities through reprogramming mechanism

Researchers have been able to reprogram cells experimentally, but few have shown that cells can change their identities under normal physiological conditions in the body, particularly in mammals.

29 Mar 2013

Researchers identify HNF1B gene that can increase risk of ovarian cancer

Researchers at Mayo Clinic Cancer Center have identified a novel gene that can contribute to a woman's susceptibility for developing ovarian cancer. Researchers identified the gene, called HNF1B, through large-scale analysis of more than 16,000 women with ovarian cancer and more than 26,000 healthy women.

28 Mar 2013

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

More than 100 women per day die from breast cancer in the United States. The odds of developing breast cancer increase for women taking hormone replacement therapy to avoid the effects of menopause.

28 Mar 2013

Study: New genetic variants may increase cancer risk

The European Collaborative Oncological Gen-Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes today a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.

28 Mar 2013

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.

28 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

Phase 2 study of REOLYSIN meets primary endpoint in patients with squamous cell lung cancer

Oncolytics Biotech Inc. today announced that it has met the primary overall statistical endpoint in its U.S. Phase 2 single arm clinical trial in patients with squamous cell carcinoma of the lung using intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel in patients with metastatic stage IIIB, or stage IV, or recurrent SCCLC who are chemotherapy naïve for their metastatic or recurrent cancer (REO 021).

28 Mar 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

28 Mar 2013

Prostate cancer prognosis tables: an interview with Dr John B. Eifler, Brady Urological Institute of Johns Hopkins

Prostate cancer is the most common cancer in men. Despite many advances in diagnosis and treatment over the past two decades, it remains the second most common cause of cancer related death in men.

28 Mar 2013

Researchers uncover DNA rearrangement process for sex determination in Tetrahymena

It's been more than 50 years since scientists discovered that the single-celled organism Tetrahymena thermophila has seven sexes. But in all that time, they've never known how each cell's sex, or "mating type," is determined.

28 Mar 2013

University of Maryland scientist selected as fellow of newly created AACR Academy

Angela H. Brodie, Ph.D., a University of Maryland scientist whose research paved the way for a new class of drugs widely used to treat breast cancer patients around the world, has been selected by the American Association for Cancer Research as a fellow of the newly created AACR Academy.

28 Mar 2013

Johns Hopkins scientists identify DNA-damaging substances in food

In a laboratory study pairing food chemistry and cancer biology, scientists at the Johns Hopkins Kimmel Cancer Center tested the potentially harmful effect of foods and flavorings on the DNA of cells.

28 Mar 2013

Children are vulnerable to eye injury while playing baseball, expert says

Baseball, America's favorite past time. From watching a child's first T-ball game to aspirations of playing in the Little League World Series, there is just something special about kids and baseball.

28 Mar 2013

Cancer News and Research

Latest Cancer News and Research

AACR recognizes scientists whose contributions to cancer field have extraordinary impact

Porter Adventist Hospital to discuss TIA and their connection to future stroke risk

Study finds HPV improves survival in African Americans with oropharyngeal cancer

Viewpoints: Budget woes leave Democrats with painful choices; David Kessler on health hazards of antibiotics in meat; the pros and cons of not hiring smokers

Study: Diabetes drug slows down ageing process by mimicking the effects of dieting

MD Anderson researchers named Fellows to new AACR academy

Drug costs and pricing issues touch hospitals, independent pharmacies

Research shows certain cells take on new identities through reprogramming mechanism

Researchers identify HNF1B gene that can increase risk of ovarian cancer

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

Study: New genetic variants may increase cancer risk

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

First Edition: March 28, 2013

Phase 2 study of REOLYSIN meets primary endpoint in patients with squamous cell lung cancer

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Prostate cancer prognosis tables: an interview with Dr John B. Eifler, Brady Urological Institute of Johns Hopkins

Researchers uncover DNA rearrangement process for sex determination in Tetrahymena

University of Maryland scientist selected as fellow of newly created AACR Academy

Johns Hopkins scientists identify DNA-damaging substances in food

Children are vulnerable to eye injury while playing baseball, expert says

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Newsletters you may be interested in